Article ID Journal Published Year Pages File Type
2034895 Bioscience Hypotheses 2009 8 Pages PDF
Abstract
Those diabetics who are retinopathy-protected & nephropathy-prone (CT & TT), should not be given aldose reductase inhibitors (which could worsen nephropathy) but the new breed of TGF-β inhibitors. This might be a first step towards “genetic individualization of diabetes therapy”.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry, Genetics and Molecular Biology (General)
Preview
The “flip-flop” of aldose reductase gene in diabetic retinopathy and nephropathy
Authors
, , ,